简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

2024-05-07 20:06

Gainers

  • FibroGen (NASDAQ:FGEN) shares rose 37.1% to $1.59 during Tuesday's pre-market session. The market value of their outstanding shares is at $158.1 million. The company's, Q1 earnings came out yesterday.
  • Envoy Medical (NASDAQ:COCH) stock moved upwards by 23.54% to $4.25. The company's market cap stands at $83.2 million.
  • iSpecimen (NASDAQ:ISPC) shares rose 21.18% to $0.33. The company's market cap stands at $3.0 million. The company's, Q1 earnings came out today.
  • NovaBay Pharmaceuticals (AMEX:NBY) shares moved upwards by 20.87% to $0.11. The company's market cap stands at $3.9 million.
  • GT Biopharma (NASDAQ:GTBP) shares rose 19.25% to $3.84. The market value of their outstanding shares is at $5.3 million.
  • Esperion Therapeutics (NASDAQ:ESPR) stock increased by 18.39% to $2.51. The company's market cap stands at $475.3 million. As per the news, the Q1 earnings report came out today.

Losers

  • Helius Medical Tech (NASDAQ:HSDT) shares decreased by 16.5% to $2.02 during Tuesday's pre-market session. The company's market cap stands at $1.7 million.
  • Cellectis (NASDAQ:CLLS) shares declined by 11.05% to $2.98. The company's market cap stands at $214.4 million.
  • Eledon Pharma (NASDAQ:ELDN) shares fell 9.43% to $2.21. The market value of their outstanding shares is at $54.8 million.
  • Fresenius Medical Care (NYSE:FMS) stock fell 8.03% to $19.7. The company's market cap stands at $11.5 billion.
  • Madrigal Pharmaceuticals (NASDAQ:MDGL) shares declined by 7.42% to $218.1. The market value of their outstanding shares is at $4.6 billion. The company's, Q1 earnings came out today.
  • Context Therapeutics (NASDAQ:CNTX) shares declined by 7.31% to $1.65. The company's market cap stands at $26.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。